Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.6K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

381
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
381
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

823
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
823
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

6.2K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dual-adjuvant mucosal vaccine leveraging mast cell and TLR9 agonists for protection against poxvirus infection.

RSC pharmaceutics·2026
Same author

Mitochondrial cardiolipin sequestration of caspofungin underlies <i>Cryptococcus neoformans</i> inherent resistance and may contribute to cardiotoxicity.

bioRxiv : the preprint server for biology·2026
Same author

Concordant and Discordant Transcriptomic Signatures of Twin Placentas in the Setting of Preeclampsia.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Targeting STK17B kinase activates ferroptosis and suppresses drug resistance in multiple myeloma.

Blood·2025
Same author

A translational review of hyperthermia biology.

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·2025
Same author

Contrasting Effects of Catecholate and Hydroxamate Siderophores on Molybdenite Dissolution.

Environmental science & technology·2024

Related Experiment Video

Updated: Dec 25, 2025

Single Molecule Analysis of Laser Localized Psoralen Adducts
11:46

Single Molecule Analysis of Laser Localized Psoralen Adducts

Published on: April 20, 2017

6.9K

Psoralen Derivatives with Enhanced Potency.

Alexandru D Buhimschi1,2, David M Gooden3, Hongwu Jing4

  • 1Medical Scientist Training Program, Northwestern University Feinberg School of Medicine, Chicago, IL.

Photochemistry and Photobiology
|March 30, 2020
PubMed
Summary

Researchers synthesized 73 novel psoralens, identifying two more potent than existing drugs. Enhanced DNA binding in these new psoralen derivatives correlated with increased cytotoxicity, offering a path for drug optimization.

More Related Videos

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

13.1K
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.6K

Related Experiment Videos

Last Updated: Dec 25, 2025

Single Molecule Analysis of Laser Localized Psoralen Adducts
11:46

Single Molecule Analysis of Laser Localized Psoralen Adducts

Published on: April 20, 2017

6.9K
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

13.1K
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.6K

Area of Science:

  • Medicinal Chemistry
  • Natural Products
  • Photochemistry

Background:

  • Psoralens are furocoumarin natural products known for DNA intercalation and covalent adduct formation upon UV activation.
  • Psoralen's efficacy is established in treating conditions like psoriasis, vitiligo, graft-versus-host disease, and cutaneous T-cell lymphoma.
  • The therapeutic relevance necessitates the development of more potent psoralen derivatives.

Purpose of the Study:

  • To synthesize a library of novel psoralen derivatives with enhanced potency.
  • To evaluate the cytotoxicity and DNA adduct formation of these novel compounds.
  • To establish structure-activity relationships for optimizing psoralen-based therapeutics.

Main Methods:

  • Synthesis of a library comprising 73 novel psoralen compounds.
  • Screening for cytotoxicity by measuring the reduction in cell proliferation.
  • Analysis of DNA adduct formation using MALDI-TOF MS.
  • Correlation of structural modifications with observed biological activity.

Main Results:

  • Identification of two novel psoralen derivatives exhibiting greater cytotoxicity than the potent 4'-aminomethyl-4,5',8-trimethylpsoralen (AMT).
  • A strong correlation was observed between enhanced DNA binding affinity and increased cytotoxicity for most novel psoralens.
  • Potent derivatives typically feature positively charged substituents, suggesting increased DNA affinity and intercalation.

Conclusions:

  • The study provides a rational strategy for optimizing psoralen derivatives to maximize their therapeutic potential.
  • Novel psoralens with enhanced potency and DNA binding capabilities have been developed.
  • Structure-activity insights offer opportunities to further investigate psoralen's mechanism of action.